QMatter, Inc.

Biotechnology company · London, England, United Kingdom

QMatter, Inc. is a biotechnology company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

QMatter at a glance

Typebiotechnology company

HeadquartersLondon, England, United Kingdom

Earliest incorporation on record2024

SEC CIK2128509

What does QMatter do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.2 million sold (2026).

Frequently asked questions about QMatter

Where is QMatter headquartered?

QMatter, Inc. is headquartered in London, England, United Kingdom.

What does QMatter do?

QMatter, Inc. is a biotechnology company.

When was QMatter founded?

The earliest incorporation on record for QMatter, Inc. is in 2024, according to public company registers.

Similar companies

Orchard Therapeutics plcLondon, England, United Kingdom
Gyroscope Therapeutics LtdLondon, England, United Kingdom
CHARM Therapeutics Inc.London, England, United Kingdom
Duke Street Bio LtdLondon, England, United Kingdom
Autolus Therapeutics plcLondon, England, United Kingdom
Oppilan Pharma LtdLondon, England, United Kingdom
OKYO Pharma LtdLondon, England, United Kingdom
Beacon Therapeutics LimitedLondon, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences